Fluvastatin - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by Almirall S.A.; Amylin Pharmaceuticals; AstraZeneca; Bayer; Mitsubishi Tanabe Pharma Corporation; Sanofi; Solvay; UCB
- Drug Class Antihyperlipidaemics; Indoles; Monounsaturated fatty acids
- Mechanism of Action HMG-CoA reductase inhibitors
- USA Patent Applicants NOVARTIS; SANDOZ
- USA Patents 2
- NDAs 2
- Patent Applications 8,181
Table of Contents

Disclaimer